In:
European Ophthalmic Review, Touch Medical Media, Ltd., Vol. 06, No. 01 ( 2012), p. 51-
Abstract:
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in adults aged over 50 years in developed countries. In 2006, the use of intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) drugs revolutionised the therapeutic approach to treating neovascular AMD. However, it is essential to detect the frequent diagnostic pitfalls encountered in this therapeutic domain to apply anti-VEGF therapy successfully and thereby avoid useless treatments. Classic pitfalls include retinal pigmented epithelium-photoreceptor abnormalities mimicking choroidal neovascularisation; persistent serous retinal detachment; pseudocysts and cystoid cavities mimicking retinal oedema; and outer retinal tubulations. Current imaging technologies, such as colour fundus photography, autofluorescence (FAF) and infrared imaging, fluorescein (FA) and indocyanine green (ICGA) angiographies, spectral domain optical coherence tomography (SD-OCT) and enhanced depth imaging OCT (EDI-OCT), can help overcome these pitfalls. Even if anti-VEGF treatments are mostly based on SD-OCT data, the consolidation and correlational analysis of all the available patient data is essential for accurate diagnosis.
Type of Medium:
Online Resource
ISSN:
1756-1795
DOI:
10.17925/EOR.2012.06.01.51
Language:
English
Publisher:
Touch Medical Media, Ltd.
Publication Date:
2012
detail.hit.zdb_id:
2433198-3
Bookmarklink